microbial strains e Search Results


poae  (ATCC)
90
ATCC poae
Poae, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/us08604062-68-22-23?v=ATCC
Average 90 stars, based on 1 article reviews
poae - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

99
ATCC gram positive bacteria
Gram Positive Bacteria, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/pmc08676445-115-17-21?v=ATCC
Average 99 stars, based on 1 article reviews
gram positive bacteria - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
Verenium Inc microbial strain
Microbial Strain, supplied by Verenium Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/pmc04315468__pbio__1002060__s001-398-8-3?v=Verenium+Inc
Average 90 stars, based on 1 article reviews
microbial strain - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Microbia Inc 2000 strains
2000 Strains, supplied by Microbia Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/10__1074_slash_jbc__m409012200-60-0-2?v=Microbia+Inc
Average 90 stars, based on 1 article reviews
2000 strains - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

98
Qiagen qiaamp dna mini kit
Qiaamp Dna Mini Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/pmc07099210-88-8-12?v=Qiagen
Average 98 stars, based on 1 article reviews
qiaamp dna mini kit - by Bioz Stars, 2026-07
98/100 stars
  Buy from Supplier

95
ATCC b microti peabody mjr
( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. <t>microti</t> in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of <t>B.</t> <t>rodhaini</t> in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.
B Microti Peabody Mjr, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/bio_rxiv__2024__07__15__603500-101-5-9?v=ATCC
Average 95 stars, based on 1 article reviews
b microti peabody mjr - by Bioz Stars, 2026-07
95/100 stars
  Buy from Supplier

94
ATCC enteric bacteria enterobacter cloacae strain jd630i
( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. <t>microti</t> in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of <t>B.</t> <t>rodhaini</t> in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.
Enteric Bacteria Enterobacter Cloacae Strain Jd630i, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/us11375734-54-8-14?v=ATCC
Average 94 stars, based on 1 article reviews
enteric bacteria enterobacter cloacae strain jd630i - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

99
ATCC microbial strains
( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. <t>microti</t> in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of <t>B.</t> <t>rodhaini</t> in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.
Microbial Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/pmc10093860-150-1-6?v=ATCC
Average 99 stars, based on 1 article reviews
microbial strains - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

99
ATCC s aureus
( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. <t>microti</t> in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of <t>B.</t> <t>rodhaini</t> in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.
S Aureus, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/pmc03561256-85-8-10?v=ATCC
Average 99 stars, based on 1 article reviews
s aureus - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

97
ATCC bacillus cereus
( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. <t>microti</t> in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of <t>B.</t> <t>rodhaini</t> in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.
Bacillus Cereus, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/10__3390_slash_applbiosci5010016-82-51-58?v=ATCC
Average 97 stars, based on 1 article reviews
bacillus cereus - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier

96
ATCC wild type microbes
( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. <t>microti</t> in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of <t>B.</t> <t>rodhaini</t> in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.
Wild Type Microbes, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/pmc04148813-258-17-25?v=ATCC
Average 96 stars, based on 1 article reviews
wild type microbes - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier

94
ATCC strain pamc 28618
( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. <t>microti</t> in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of <t>B.</t> <t>rodhaini</t> in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.
Strain Pamc 28618, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microbial+strains+e/pmc05438365-31-43-56?v=ATCC
Average 94 stars, based on 1 article reviews
strain pamc 28618 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

Image Search Results


( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. microti in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. rodhaini in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.

Journal: bioRxiv

Article Title: Efficacy and mechanism of actions of cipargamin as an antibabesial drug candidate

doi: 10.1101/2024.07.15.603500

Figure Lengend Snippet: ( A ) and ( B) Dose-dependent growth curve of CIP on B. bovis and B. gibsoni in vitro . Each value represents the mean ± standard deviation (SD) of three independent experiments carried out in triplicate. ( C) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. microti in BALB/c mice. ( D) Hematocrit (HCT) values in mice treated with CIP or ATO plus AZI compared with vehicle-treated mice. ( E) Inhibitory effects of CIP and atovaquone (ATO) plus azithromycin (AZI) on the proliferation of B. rodhaini in BALB/c mice. ( F) Survival rates of CIP-treated, ATO plus AZI-treated, and vehicle-treated mice. The treatment time is shown by arrows, and significant differences ( P < 0.01) between the drug-treated groups and the vehicle-treated control group are indicated by asterisks. The data from one of six individual experiments are expressed as means ± SD. *, P ˂ 0.05; **, P ˂ 0.01.

Article Snippet: For the in vivo studies, B. microti Peabody mjr strain-(ATCC PRA-99) and B. rodhaini Australia strain-infected RBCs (iRBCs), which were collected and diluted with phosphate-buffered saline (PBS) when the parasitemia levels in the donor mice reached ∼20% and 50%, respectively, and were intraperitoneally injected into BALB/c mice.

Techniques: In Vitro, Standard Deviation, Control